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Introduction
white matter disease.
Ophthalmological examination revealed no light perception, bilaterally dilated fixed pupils, bilateral optic A number of medical emergencies may be provoked atrophy and attenuated retinal vessels as shown in by haemodialysis sessions. We wish to draw the atten- Figure 1 . Fundus fluorescein angiogram revealed tion of the reader to a rare, but catastrophic, ophthalnormal vascular filling, staining of the optic disks and mic complication of dialysis.
an essentially normal fluorescein angiogram. The electroretinogram was normal as was cerebral angiography.
Case report
Subsequently her dry weight was increased by 5% of body weight. Predialysis blood pressure remained A 40-year-old non-diabetic woman with unknown around 95/65 mmHg and vision remained permanprimary renal disease had been on regular haemodiaently lost. lysis for 3 years. She suffered from autonomic neuropathy and chronic systemic hypotension (average pre-dialysis blood pressure 95/60 mmHg).
Discussion
During a routine haemodialysis session, using polysulfone dialyser and bicarbonate buffer, her blood pres-The pathophysiology of optic neuropathy in end-stage sure at the end of the 4-h dialysis session decreased to renal disease is heterogenous affecting patients with 80/45 mmHg. After haemodialysis had been terminated profound uraemia and patients on maintenance dialytic she suddenly complained of loss of vision in the right therapy. Acute loss of vision in uraemia has been eye. Twenty-four hours later the vision was also lost related to oedema of the occipital cortex, a syndrome in the left eye and she became totally blind. An known as uraemic amaurosis but with prompt dialysis ophthalmologist diagnosed giant-cell arteritis. He pre-visual function is reversible [1] . In uraemia the optic scribed methylprednisone 1 g i.v. for 5 days followed nerve is susceptible to ischaemia and in two dialysis by oral prednisone 60 mg/day. Vision did not recover. patients there was significant permanent visual loss
The next ophthalmologist noted bilateral fixed from hypotension-induced ischaemic optic atrophy dilatation of pupils and normal extra-ocular motility. during haemodialysis [2, 3] . In the course of haemodiaDilated fundus examination showed bilateral ischaemic lysis, hypotension is the most frequent complication occurring in~25% of cases and its origin is generally A. Sabeel et al. 2958 visual loss is characteristically of sudden onset, not associated with pain or other symptoms [7] . Anaemia is a risk factor predisposing to ischaemic optic neuropathy. Our patient's low haemoglobin (7.4 g/l ) might also have accelerated the course of visual loss.
Ischaemic optic neuropathy in both arteritic and nonarteritic forms is the most common cause of neurogenic visual loss in adults [7] . Our patient had features of the nonarteritic ischaemic optic neuropathy as her blindness was sudden and painless [6 ] . She did not have any symptoms of giant-cell arteritis or other associated systemic disease. She was not on medications that could cause ocular toxicity. The loss of vision was preceded by profound hypotension. Giantcell arteritis was suspected by an ophthalmologist and she received treatment with systemic steroids and plasmapheresis without response. In the acute phase it may be difficult on clinical grounds to differentiate between optic neuritis and nonarteritic ischaemic optic neuropathy as the clinical profiles may overlap [7] . No effective treatment is available for nonarteritic ischaemic optic neuropathy. Early aggressive intervention to restore perfusion by increasing blood pressure and haematocrit may result in partial recovery of vision [3] . The natural history of ischaemic optic neuropathy is not fully defined, but in the majority of patients, visual loss is maximal within 24 h. After a follow-up period exceeding 4 months, an overall spontaneous improvement of vision occur in no more than 16% of cases [7] . In our patient there was no light perception after six months of follow-up.
Teaching point
Dialysis patients with arteriosclerothic vascular disease (a) (b) are at the risk of developing ischaemic optic neuro- Fig. 1 . Fundus photograph showing optic atrophy and attenuated pathy during intradialytic hypotensive episodes. blood vessels.
